MedPath

A novel bundled intervention (4D’s) to improve adherence with phosphate control in people receiving haemodialysis for end stage kidney disease.

Not Applicable
Completed
Conditions
Chronic kidney disease
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12617000703303
Lead Sponsor
Queensland University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

Age (18 years and over)
End stage kidney disease undergoing in-centre haemodialysis (three times per week) for at least three months
Able to speak English language
Elevated average serum phosphate levels of >1.6mmol/L for the previous three months before the study
Willing to participate

Exclusion Criteria

Malnourished (as protein intake takes precedence over phosphate control)
Receiving or under going home haemodialysis
Diagnosed with functional psychosis or organic brain disorder
Living in a nursing home as it is difficult for them to self-manage
Receiving palliative treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome<br>Serum phosphate levels obtained from clinical laboratory results[Time point 1= Baseline<br>Repeated measurement: Time point 2 = week 4, Time point 3 = week 8, Time point 4 = week 12 (intervention conclusion) ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath